The University of Chicago Header Logo

Connection

David T. Rubin to Liver Diseases

This is a "connection" page, showing publications David T. Rubin has written about Liver Diseases.
Connection Strength

0.560
  1. Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease-Authors' reply. Aliment Pharmacol Ther. 2018 05; 47(10):1423-1424.
    View in: PubMed
    Score: 0.560
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.